RON was originally described as a transmembrane receptor localized to tissue-specific macrophages and epithelial cells that when overexpressed modifies intrinsic cell signaling pathways with subsequent changes in tumor cells, immune interactions, and the microenvironment promoting disease phenotype. The gene discussed is MST1R; the disease is neoplasm.